Alan Reider is a Partner in the FDA and Healthcare practice group with more than 30 years of experience representing national healthcare corporations, pharmaceutical and medical device companies, as well as institutional providers and individual practitioners and suppliers. His practice focuses on compliance and fraud and abuse counseling, as well as on reimbursement and coverage and certification issues and on relationships with third party payors. He has defended providers and practitioners in Anti-Kickback, Stark law, False Claims Act, Civil Money Penalty, and suspension and exclusion actions. Mr. Reider has extensive experience performing regulatory due diligence in connection with potential acquisition targets, developing compliance programs, and negotiating Corporate Integrity Agreements. He frequently appears before federal agencies, including Centers for Medicare and Medicaid Services, Office of Inspector General, United States Department of Justice, and state attorneys general offices throughout the country.

Mr. Reider has defended hospitals, ambulatory surgery centers, physicians, suppliers, and pharmaceutical companies in government enforcement actions. For example, he has:

Served as lead defense counsel in the government investigation of National Medical Care—at the time, the largest healthcare fraud case in history
Served as one of the principal defense attorneys in the landmark National Health Laboratories settlement, the first major healthcare False Claims Act case

Mr. Reider's work in the healthcare regulatory area extends to all parts of the healthcare industry. For example, he has:

Developed compliance programs for large national healthcare companies and individual providers, including hospitals, nursing homes, suppliers, and physician practices
Published model compliance documents for national physician professional societies
Assisted in the development of marketing guidelines for national pharmaceutical and medical device companies
Advised a broad range of healthcare entities on structuring joint ventures and performed due diligence in connection with the acquisition of a wide variety of healthcare facilities
Assisted medical device and pharmaceutical companies in obtaining Medicare coverage for off-label uses and has represented companies before the Centers for Medicare and Medicaid Services in petitioning for changes in reimbursement across all payment methodologies

Prior to joining the private sector, Mr. Reider spent five years in the Health Care Financing Administration (now known as the Centers for Medicare and Medicaid Services) of the United States Department of Health & Human Services. During his tenure in the Department, he worked in the Office of Program Integrity and the Office of Professional Standards Review Organizations, where he was chief of the review policy branch.

Mr. Reider frequently lectures at healthcare meetings throughout the country, particularly relating to fraud and abuse and compliance related topics. He has also published several book chapters and is a frequent contributor to health industry periodicals.